Which TNF inhibitor has an intravenous dosing option of 2 mg/kg?

Enhance your dermatological knowledge with the Dermatology Week 1 Exam. Engage with multiple choice questions that provide insights and detailed explanations to gear you up for testing success. Prepare effectively for your exam!

Multiple Choice

Which TNF inhibitor has an intravenous dosing option of 2 mg/kg?

Explanation:
TNF inhibitors differ in how you give them and how the dose is determined. Among these agents, only one is given intravenously with a weight-based dose of 2 mg/kg. This IV regimen is administered as an infusion at the start and again at week 4, then every 8 weeks thereafter. The other drugs are used mainly as subcutaneous injections with fixed dosing schedules: one is given as 40 mg SC every other week, another as 50 mg SC weekly, and the last with loading doses of 400 mg at weeks 0, 2, and 4 followed by 200 mg every 2 weeks. So the 2 mg/kg IV option specifically points to golimumab.

TNF inhibitors differ in how you give them and how the dose is determined. Among these agents, only one is given intravenously with a weight-based dose of 2 mg/kg. This IV regimen is administered as an infusion at the start and again at week 4, then every 8 weeks thereafter. The other drugs are used mainly as subcutaneous injections with fixed dosing schedules: one is given as 40 mg SC every other week, another as 50 mg SC weekly, and the last with loading doses of 400 mg at weeks 0, 2, and 4 followed by 200 mg every 2 weeks. So the 2 mg/kg IV option specifically points to golimumab.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy